Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-011672
Filing Date
2016-07-21
Accepted
2016-07-21 14:32:55
Documents
28
Period of Report
2016-05-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 209070
2 ex31.htm EX-31 9452
3 ex32.htm EX-32 4796
  Complete submission text file 0001493152-16-011672.txt   784523

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE ptlf-20160531.xml EX-101.INS 56053
5 XBRL SCHEMA FILE ptlf-20160531.xsd EX-101.SCH 10900
6 XBRL CALCULATION FILE ptlf-20160531_cal.xml EX-101.CAL 18461
7 XBRL DEFINITION FILE ptlf-20160531_def.xml EX-101.DEF 19767
8 XBRL LABEL FILE ptlf-20160531_lab.xml EX-101.LAB 76250
9 XBRL PRESENTATION FILE ptlf-20160531_pre.xml EX-101.PRE 55091
Mailing Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210
Business Address 433 N. CAMDEN DR. BEVERLY HILLS CA 90210 (310) 279-5152
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

EIN.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 161777259
SIC: 2860 Industrial Organic Chemicals